Home Healthcare Pharmaceuticals Chronic Disease Management Market

Chronic Disease Management Market Size, Share & Trends Analysis Report By Offerings (Solutions, Services), By Delivery Mode (On-premise, Cloud-based), By Disease Indication (Diabetes, Cardiovascular Diseases, Respiratory Diseases, Cancer, Chronic Kidney Disease (CKD), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Chronic Disease Management Market, By Offerings 2022-2034 (USD MILLION/ Units)
    1. Solutions
    2. Services
  2. Chronic Disease Management Market, By Delivery Mode 2022-2034 (USD MILLION/ Units)
    1. On-premise
    2. Cloud-based
  3. Chronic Disease Management Market, By Disease Indication 2022-2034 (USD MILLION/ Units)
    1. Diabetes
    2. Cardiovascular Diseases
    3. Respiratory Diseases
    4. Cancer
    5. Chronic Kidney Disease (CKD)
    6. Others
  4. Regional Chronic Disease Management Market
    1. North America
      1. North America Chronic Disease Management Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Solutions
        2. Services
      2. North America Chronic Disease Management Market By Delivery Mode 2022-2034 (USD MILLION/ Units)
        1. On-premise
        2. Cloud-based
      3. North America Chronic Disease Management Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Diabetes
        2. Cardiovascular Diseases
        3. Respiratory Diseases
        4. Cancer
        5. Chronic Kidney Disease (CKD)
        6. Others
      4. U.S.
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      5. Canada
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
    2. Europe
      1. Europe Chronic Disease Management Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Solutions
        2. Services
      2. Europe Chronic Disease Management Market By Delivery Mode 2022-2034 (USD MILLION/ Units)
        1. On-premise
        2. Cloud-based
      3. Europe Chronic Disease Management Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Diabetes
        2. Cardiovascular Diseases
        3. Respiratory Diseases
        4. Cancer
        5. Chronic Kidney Disease (CKD)
        6. Others
      4. U.K.
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      5. Germany
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      6. France
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      7. Spain
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      8. Italy
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      9. Russia
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      10. Nordic
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      11. Benelux
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      12. Rest of Europe
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
    3. APAC
      1. APAC Chronic Disease Management Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Solutions
        2. Services
      2. APAC Chronic Disease Management Market By Delivery Mode 2022-2034 (USD MILLION/ Units)
        1. On-premise
        2. Cloud-based
      3. APAC Chronic Disease Management Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Diabetes
        2. Cardiovascular Diseases
        3. Respiratory Diseases
        4. Cancer
        5. Chronic Kidney Disease (CKD)
        6. Others
      4. China
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      5. Korea
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      6. Japan
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      7. India
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      8. Australia
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      9. Taiwan
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      10. South East Asia
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      11. Rest of Asia-Pacific
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Chronic Disease Management Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Solutions
        2. Services
      2. Middle East and Africa Chronic Disease Management Market By Delivery Mode 2022-2034 (USD MILLION/ Units)
        1. On-premise
        2. Cloud-based
      3. Middle East and Africa Chronic Disease Management Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Diabetes
        2. Cardiovascular Diseases
        3. Respiratory Diseases
        4. Cancer
        5. Chronic Kidney Disease (CKD)
        6. Others
      4. UAE
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      5. Turkey
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      6. Saudi Arabia
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      7. South Africa
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      8. Egypt
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      9. Nigeria
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      10. Rest of MEA
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
    5. LATAM
      1. LATAM Chronic Disease Management Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Solutions
        2. Services
      2. LATAM Chronic Disease Management Market By Delivery Mode 2022-2034 (USD MILLION/ Units)
        1. On-premise
        2. Cloud-based
      3. LATAM Chronic Disease Management Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Diabetes
        2. Cardiovascular Diseases
        3. Respiratory Diseases
        4. Cancer
        5. Chronic Kidney Disease (CKD)
        6. Others
      4. Brazil
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      5. Mexico
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      6. Argentina
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      7. Chile
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      8. Colombia
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
      9. Rest of LATAM
        1. Solutions
        2. Services
        3. On-premise
        4. Cloud-based
        5. Diabetes
        6. Cardiovascular Diseases
        7. Respiratory Diseases
        8. Cancer
        9. Chronic Kidney Disease (CKD)
        10. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.